NICE Recommends Tysabri For Use In Highly Active Relapsing Remitting Multiple Sclerosis
Medical News Today Fri, 24 Aug 2007 2:11 AM PDT
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) welcome final guidance announced by the National Institute for Health and Clinical Excellence (NICE) recommending use of TYSABRI (natalizumab) in people with highly active relapsing remitting multiple sclerosis (RRMS). TYSABRI is the first treatment for multiple sclerosis to be recommended for use by NICE. [click link for full ...

Fish Oil Might Help Relieve MS
HealthDay via Yahoo! News Fri, 24 Aug 2007 9:04 AM PDT
FRIDAY, Aug. 24 (HealthDay News) -- Fish oil containing omega-3 fatty acids could benefit multiple sclerosis (MS) patients, a U.S. study finds.